Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Silicone Hydrogel Lens Wettability With Marketed Lens Care Solutions (SILVER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01252134
Recruitment Status : Completed
First Posted : December 2, 2010
Results First Posted : June 11, 2012
Last Update Posted : June 11, 2012
Sponsor:
Information provided by (Responsible Party):
Alcon Research

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to assess ex vivo wettability of a commonly prescribed silicone hydrogel (SiH) contact lens with three marketed contact lens care solutions.

Condition or disease Intervention/treatment Phase
Contact Lens Wear Device: Biotrue multipurpose solution Device: Sauflon Synergi multipurpose solution Device: OTE Elements multipurpose solution Device: Silicone hydrogel contact lenses (Acuvue Advance) Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 22 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Supportive Care
Official Title: The Evaluation of Silicone Hydrogel Lens Wettability With Marketed Lens Care Solutions
Study Start Date : November 2010
Actual Primary Completion Date : February 2011
Actual Study Completion Date : February 2011
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Synergi, then Biotrue, then OTE
Three lens care systems randomly assigned. Contact lenses were pre-soaked overnight prior to insertion, then worn for 8 hours, with a minimum two-day washout between each wear period.
 Device: Biotrue multipurpose solution
Contact lens care solution

Device: Sauflon Synergi multipurpose solution
Contact lens care solution

Device: OTE Elements multipurpose solution
Contact lens care solution

Device: Silicone hydrogel contact lenses (Acuvue Advance)
Commercially marketed contact lenses
Other Name: Acuvue® Advance™
Synergi, then OTE, then Biotrue
Three lens care systems randomly assigned. Contact lenses were pre-soaked overnight prior to insertion, then worn for 8 hours, with a minimum two-day washout between each wear period.
 Device: Biotrue multipurpose solution
Contact lens care solution

Device: Sauflon Synergi multipurpose solution
Contact lens care solution

Device: OTE Elements multipurpose solution
Contact lens care solution

Device: Silicone hydrogel contact lenses (Acuvue Advance)
Commercially marketed contact lenses
Other Name: Acuvue® Advance™
Biotrue, then OTE, then Synergi
Three lens care systems randomly assigned. Contact lenses were pre-soaked overnight prior to insertion, then worn for 8 hours, with a minimum two-day washout between each wear period.
 Device: Biotrue multipurpose solution
Contact lens care solution

Device: Sauflon Synergi multipurpose solution
Contact lens care solution

Device: OTE Elements multipurpose solution
Contact lens care solution

Device: Silicone hydrogel contact lenses (Acuvue Advance)
Commercially marketed contact lenses
Other Name: Acuvue® Advance™
Biotrue, then Synergi, then OTE
Three lens care systems randomly assigned. Contact lenses were pre-soaked overnight prior to insertion, then worn for 8 hours, with a minimum two-day washout between each wear period.
 Device: Biotrue multipurpose solution
Contact lens care solution

Device: Sauflon Synergi multipurpose solution
Contact lens care solution

Device: OTE Elements multipurpose solution
Contact lens care solution

Device: Silicone hydrogel contact lenses (Acuvue Advance)
Commercially marketed contact lenses
Other Name: Acuvue® Advance™
OTE, then Biotrue, then Synergi
Three lens care systems randomly assigned. Contact lenses were pre-soaked overnight prior to insertion, then worn for 8 hours, with a minimum two-day washout between each wear period.
 Device: Biotrue multipurpose solution
Contact lens care solution

Device: Sauflon Synergi multipurpose solution
Contact lens care solution

Device: OTE Elements multipurpose solution
Contact lens care solution

Device: Silicone hydrogel contact lenses (Acuvue Advance)
Commercially marketed contact lenses
Other Name: Acuvue® Advance™
OTE, then Synergi, then Biotrue
Three lens care systems randomly assigned. Contact lenses were pre-soaked overnight prior to insertion, then worn for 8 hours, with a minimum two-day washout between each wear period.
 Device: Biotrue multipurpose solution
Contact lens care solution

Device: Sauflon Synergi multipurpose solution
Contact lens care solution

Device: OTE Elements multipurpose solution
Contact lens care solution

Device: Silicone hydrogel contact lenses (Acuvue Advance)
Commercially marketed contact lenses
Other Name: Acuvue® Advance™


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Ex Vivo Contact Angle [ Time Frame: 8 hours ]
    Study lens was removed from the eye according to protocol-specified procedures. The OCA15 Dynamic Contact Angle Instrument was used to observe, record, and calculate contact angle measurements. The measurements from the right eye and left eye were averaged. A lower contact angle measurement indicates a more wettable lens.


Secondary Outcome Measures :
  1. Subjective Comfort [ Time Frame: 8 hours ]
    Subjective comfort was assessed by the participant on a scale of 0 to 100, with 0 being very poor comfort and 100 being excellent comfort. The ratings for the right eye and left eye were averaged.

  2. Corneal Staining Type [ Time Frame: 8 hours ]
    Five regions of the cornea (central, inferior, temporal, superior, and nasal) were evaluated for staining using cobalt light and a #12 Wratten filter. The type of staining was recorded on a scale of 0 to 100 for each corneal region with 0-none, 25=micropunctate, 50=macropunctate, 75=coalescent, and 100=patch. The five regions for each eye were averaged, and the eyes were averaged.

  3. Corneal Staining Extent [ Time Frame: 8 hours ]
    Area (extent) of corneal staining was estimated for each of the five regions of the cornea as a percentage i.e., 0%=no staining in the region and 100%=staining covering the entire region). A staining area percentage was calculated for each eye based on the average staining area measured across all five regions, and the eyes were averaged.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age
  • Soft contact lens wear on a daily wear basis
  • Able to wear lenses at least 8 hours
  • Generally healthy with normal ocular health
  • Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

  • Use of additional lens cleaners
  • Known sensitivities to any ingredient in any of the study products
  • History of ocular surgery/trauma within the last 6 months
  • Other protocol-defined exclusion criteria may apply
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

No Contacts or Locations Provided
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT01252134    
Other Study ID Numbers: RDG10078 / SILVER
First Posted: December 2, 2010    Key Record Dates
Results First Posted: June 11, 2012
Last Update Posted: June 11, 2012
Last Verified: May 2012
Keywords provided by Alcon Research:
Soft Contact lens
Multi-purpose solution
Wettability
Additional relevant MeSH terms:
Layout table for MeSH terms
Pharmaceutical Solutions